menu
    • menu

    Company profile for RevolKa

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RevolKa is at the forefront of next-generation protein engineering, dedicated to pioneering the discovery and advancement of innovative proteins. Our commitment to innovation is driven by our proprietary artificial intelligence-integrated directed protein evolution technology, known as aiProtein®. With this cutting-edge technology at our disposal, RevolKa is deeply passionate about creating novel proteins and pushing the boun...
    RevolKa is at the forefront of next-generation protein engineering, dedicated to pioneering the discovery and advancement of innovative proteins. Our commitment to innovation is driven by our proprietary artificial intelligence-integrated directed protein evolution technology, known as aiProtein®. With this cutting-edge technology at our disposal, RevolKa is deeply passionate about creating novel proteins and pushing the boundaries of protein engineering.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RevolKajapan Flag
    Country
    Country
    Japan
    Address
    Address
    Bunkyo-ku, Tokyo 113-0033
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.revolka.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/revolka-ltd/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RevolKa Ltd. Joins Japanese AMED Biologics R&D Program
    RevolKa Ltd. Joins Japanese AMED Biologics R&D Program

    30 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250624791181/en/RevolKa-Ltd.-Joins-Research-and-Development-Program-for-Innovative-Biologics-Funded-by-the-Japanese-Agency-for-Medical-Research-and-Development-AMED

    BUSINESSWIRE
    30 Jun 2025
    Share Share
    RevolKa secures 210M JPY Series A Extension funding
    RevolKa secures 210M JPY Series A Extension funding

    19 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250515666172/en/RevolKa-Ltd.-Secures-210-million-JPY-US%241.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs

    BUSINESSWIRE
    19 May 2025
    Share Share
    RevolKa Closes $1.7M Series A Extension For Drug Discovery Programs
    RevolKa Closes $1.7M Series A Extension For Drug Discovery Programs

    29 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240829233717/en

    BUSINESSWIRE
    29 Aug 2024
    Share Share
    RevolKa enters master service agreement with Daiichi Sankyo
    RevolKa enters master service agreement with Daiichi Sankyo

    29 May 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169408&sid=2

    PHARMABIZ
    29 May 2024
    Share Share
    RevolKa Signs Master Service Agreement with Daiichi Sankyo
    RevolKa Signs Master Service Agreement with Daiichi Sankyo

    28 May 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-05-28/revolka-signs-master-service-agreement-with-daiichi-sankyo/?widget=listSection

    CONTRACT PHARMA
    28 May 2024
    Share Share
    RevolKa Signed Master Service Agreement with Daiichi Sankyo
    RevolKa Signed Master Service Agreement with Daiichi Sankyo

    27 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240527930585/en

    BUSINESSWIRE
    27 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search